Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

TCON

TRACON Pharmaceuticals (TCON)

TRACON Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TCON
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
14/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
13/05/202423h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCONTRACON Pharmaceuticals Inc
13/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
07/03/202423h03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCONTRACON Pharmaceuticals Inc
05/03/202423h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCONTRACON Pharmaceuticals Inc
28/02/202422h02GlobeNewswire Inc.TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202422h31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
09/02/202422h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
19/12/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
08/12/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
20/11/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
09/11/202323h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
06/10/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
18/09/202314h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
07/09/202322h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
14/08/202323h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
14/08/202322h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
07/08/202323h02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
25/07/202323h19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
11/07/202314h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
20/06/202314h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
15/06/202314h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
09/06/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
02/06/202323h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
02/06/202322h47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCONTRACON Pharmaceuticals Inc
01/06/202312h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCONTRACON Pharmaceuticals Inc
31/05/202322h22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TCONTRACON Pharmaceuticals Inc
19/05/202323h02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:TCONTRACON Pharmaceuticals Inc
10/05/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TCON